Allogeneic CD19-CAR T cells: a promising treatment for pediatric patients with highly refractory BCP-ALL relapsing after allogeneic hematopoietic stem cells transplant (allo-HSCT)

被引：0
|
作者：
Del Bufalo, F. [1 ]
Quintarelli, C. [1 ]
Del Baldo, G. [1 ]
Merli, P. [1 ]
Boccieri, E. [1 ]
Quagliarella, F. [1 ]
Galaverna, F. [1 ]
Algeri, M. [1 ]
Pagliara, D. [1 ]
Becilli, M. [1 ]
Carta, R. [1 ]
Catanoso, M. L. [1 ]
Gunetti, M. [1 ]
Iacovelli, S. [1 ]
Bertaina, V. [1 ]
Sinibaldi, M. [1 ]
Di Cecca, S. [1 ]
Rosignoli, C. [1 ]
Leone, G. [1 ]
Pira, G. Li [1 ]
De Angelis, B. [1 ]
Locatelli, F. [1 ,2 ]
机构：
[1] Bambino Gesu Pediat Hosp, Rome, Italy
[2] Sapienza Univ, Rome, Italy
来源：
BONE MARROW TRANSPLANTATION | 2022年 / 57卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O035
引用
收藏
页码：31 / 31
页数：1
相关论文
共 50 条
  • [1] Allogeneic, donor-derived, second-generation, CD19-directed CAR-T cells for the treatment of pediatric relapsed/refractory BCP-ALL
    del Bufalo, Francesca
    Becilli, Marco
    Rosignoli, Chiara
    De Angelis, Biagio
    Algeri, Mattia
    Hanssens, Linda
    Gunetti, Monica
    Iacovelli, Stefano
    Li Pira, Giuseppina
    Girolami, Elia
    Leone, Giovanna
    Lazzaro, Stefania
    Bertaina, Valentina
    Sinibaldi, Matilde
    Di Cecca, Stefano
    Iaffaldano, Laura
    Kunkele, Annette
    Boccieri, Emilia
    Del Baldo, Giada
    Pagliara, Daria
    Merli, Pietro
    Carta, Roberto
    Quintarelli, Concetta
    Locatelli, Franco
    BLOOD, 2023, 142 (02) : 146 - 157
  • [2] Epidemiology of invasive pulmonary mycoses in children and adolescents after allogeneic hematopoietic stem cells transplantation (allo-HSCT)
    Volkova, A. G.
    Popova, M. O.
    Shadrivova, O. V.
    Bogomolova, T. S.
    Ignatyeva, S. M.
    Zyuzgin, I. S.
    Zubarovskaya, L. S.
    Klimko, N. N.
    Afanasyev, B. V.
    MYCOSES, 2013, 56 : 95 - 95
  • [3] Low Density Granulocytes in Patients after Allogeneic Hematopoietic Stem Cells Transplantation (allo-HSCT): A Distinct Class of Neutrophils in Systemic Alloimmunity
    Mikhaltsova, Ekaterina
    Savchenko, Valeri G.
    Kuzmina, Larisa A.
    Drokov, Mikhail
    Vasilyeva, Vera
    Koroleva, Olga
    Dubnyak, Daria
    Parovichnikova, Elena N.
    BLOOD, 2015, 126 (23)
  • [4] Evaluation of safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells in pediatric bronchiolitis obliterans syndrome (BoS) after allogeneic hematopoietic stem cell transplantation (allo-HSCT)
    Mohseni, Rashin
    Sharif, Pouya Mahdavi
    Behfar, Maryam
    Modaresi, Mohammad Reza
    Shirzadi, Rohola
    Mardani, Mahta
    Jafari, Leila
    Jafari, Fahimeh
    Nikfetrat, Zeynab
    Hamidieh, Amir Ali
    STEM CELL RESEARCH & THERAPY, 2023, 14 (01)
  • [5] Evaluation of safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells in pediatric bronchiolitis obliterans syndrome (BoS) after allogeneic hematopoietic stem cell transplantation (allo-HSCT)
    Rashin Mohseni
    Pouya Mahdavi Sharif
    Maryam Behfar
    Mohammad Reza Modaresi
    Rohola Shirzadi
    Mahta Mardani
    Leila Jafari
    Fahimeh Jafari
    Zeynab Nikfetrat
    Amir Ali Hamidieh
    Stem Cell Research & Therapy, 14
  • [6] CD19 Targeted Allogeneic EBV-Specific T Cells for the Treatment of Relapsed ALL in Pediatric Patients Post HSCT
    Curran, Kevin J.
    Kernan, Nancy A.
    Wang, Xiuyan
    Taylor, Clare
    Doubrovina, Ekaterina
    Bartido, Shirley
    Sadelain, Michel
    O'Reilly, Richard J.
    Brentjens, Renier J.
    Riviere, Isabelle
    BLOOD, 2012, 120 (21)
  • [7] Allogeneic Donor-Derived Anti-CD19 CAR T Cell Is a Promising Therapy for Relapsed/Refractory B-ALL After Allogeneic Hematopoietic Stem-Cell Transplantation
    Hua, Jingsheng
    Zhang, Jian
    Wu, Xiaoxia
    Zhou, Lili
    Bao, Xiebing
    Han, Yue
    Miao, Miao
    Li, Caixia
    Fu, Zhengzheng
    Wu, Depei
    Qian, Weiqing
    Qiu, Huiying
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (09): : 610 - 616
  • [8] Efficacy and Safety of Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for 67 Pediatric Patients with High Risk T-Cell Acute Lymphoblastic Leukemia (T-ALL)
    Sun, Rui-Juan
    Wei, Zhi-Jie
    Liu, De-Yan
    Cao, Xing-Yu
    Zhang, Jian-Ping
    Xiong, Min
    Zhao, Yan-Li
    Zhou, Jia-Rui
    Lu, Yue
    Lu, Pei-Hua
    Lu, DaoPei
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [9] Allogeneic Hematopoietic Cell Transplantation Is Critical to Maintain Remissions after CD19-CAR T-Cell Therapy for Pediatric ALL: A Single Center Experience
    Talleur, Aimee C.
    Madden, Renee M.
    Qudeimat, Amr
    Mamcarz, Ewelina
    Sharma, Akshay
    Srinivasan, Ashok
    Suliman, Ali Y.
    Velasquez, Mireya Paulina
    Lockey, Timothy
    Gaboriault, Alisha
    Karol, Seth E.
    Inaba, Hiroto
    Li, Ying
    Young, Pam
    Kang, Guolian
    Cheng, Cheng
    Zheng, Wenting
    Zhou, Sheng
    Akel, Salem M.
    Geiger, Terrence L.
    Meagher, Michael M.
    Pui, Ching-Hon
    Triplett, Brandon M.
    Gottschalk, Stephen
    BLOOD, 2020, 136
  • [10] PREDICTIVE SIGNIFICANCE OF CHIMERIC ANALYSIS AFTER ALLOGENEIC TRANSPLANT OF HEMATOPOIETIC STEM CELLS IN PEDIATRIC PATIENTS
    Di Martino, D.
    Terranova, M. P.
    Di Duca, M.
    Lanino, E.
    Dini, G.
    Morreale, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : S20 - S20
12345